[Diabetes mellitus in old age].
Diabetes mellitus im Alter.
COVID-19
Diabetes technology
Drug therapy
Geriatric assessment
Hypoglycemia
Journal
Zeitschrift fur Gerontologie und Geriatrie
ISSN: 1435-1269
Titre abrégé: Z Gerontol Geriatr
Pays: Germany
ID NLM: 9506215
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
30
07
2020
accepted:
01
09
2020
pubmed:
27
11
2020
medline:
30
1
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
In the treatment of diabetes in old age cognitive, functional and constitutional resources of the individual must be taken into account. Purely glycated hemoglobin (HbA1c)-oriented treatment goals are less relevant. The primary focus should be freedom from symptoms while avoiding hypoglycemia and maintaining the quality of life. The geriatric assessment helps to clarify the current functional, psychological and cognitive status as well as the need for support in multimorbid older people and to define appropriate treatment strategies. With drug treatment of diabetes in old age, particular attention must be paid to renal insufficiency and dehydration as well as slow dose adjustments. According to the Robert Koch Institute (RKI), diabetes patients belong to the risk group for a severe course of the coronavirus disease 2019 (COVID-19); further risk factors are high blood pressure, underlying oncological diseases, cerebrovascular and coronary heart diseases. Bei der Diabetestherapie im hohen Lebensalter müssen kognitive, funktionelle und konstitutionelle Ressourcen des Einzelnen beachtet werden. Rein Hämoglobin(Hb)A
Autres résumés
Type: Publisher
(ger)
Bei der Diabetestherapie im hohen Lebensalter müssen kognitive, funktionelle und konstitutionelle Ressourcen des Einzelnen beachtet werden. Rein Hämoglobin(Hb)A
Identifiants
pubmed: 33242104
doi: 10.1007/s00391-020-01815-1
pii: 10.1007/s00391-020-01815-1
pmc: PMC7689191
doi:
Substances chimiques
Glycated Hemoglobin A
0
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
61-71Références
N Engl J Med. 2019 Nov 21;381(21):2063-2064
pubmed: 31535828
Age Ageing. 1995 May;24(3):257-8
pubmed: 7645449
Drugs Aging. 2019 May;36(5):481-484
pubmed: 30941728
Patient Educ Couns. 2014 Mar;94(3):417-22
pubmed: 24341962
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Dtsch Arztebl Int. 2016 Mar 18;113(11):177-82
pubmed: 27118665
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):721-733
pubmed: 31016897
Cell Metab. 2019 Oct 1;30(4):609-613
pubmed: 31477497
Circ Res. 2018 May 11;122(10):1439-1459
pubmed: 29748368
Age Ageing. 2009 Jul;38(4):390-6
pubmed: 19454403
N Engl J Med. 2017 Jun 15;376(24):2367-2375
pubmed: 28614678
N Engl J Med. 2016 Jul 28;375(4):323-34
pubmed: 27299675
Diabetes Care. 2010 Jul;33(7):1497-9
pubmed: 20413515
MMW Fortschr Med. 2005 Feb 17;147(7):37, 39-40
pubmed: 18437873
N Engl J Med. 2019 Sep 26;381(13):1293
pubmed: 31553850
Patient Educ Couns. 2008 Oct;73(1):50-9
pubmed: 18583087
J Am Med Dir Assoc. 2012 Jan;13(1):81.e15-8
pubmed: 21450217
Diabetes Care. 2012 Aug;35(8):1672-9
pubmed: 22596176
JAMA. 2011 Jan 5;305(1):50-8
pubmed: 21205966
Diabetes Metab Res Rev. 2016 Mar;32(3):316-24
pubmed: 26409039
J Am Med Dir Assoc. 2013 Aug;14(8):585-92
pubmed: 23537893
Z Gerontol Geriatr. 2019 Jul;52(4):391-392
pubmed: 31147774
PLoS Med. 2019 Dec 9;16(12):e1002983
pubmed: 31815931
Eur Heart J. 2016 May 14;37(19):1526-34
pubmed: 26819227